Gibralt US

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Apr 16, 2014	Epirus Biopharmaceuticals	$36.0M Series B	Daotian Fu	5AM Ventures, Adage Capital Management, Greenwoods Investment, Monashee Investment Management, Montreux Equity Partners, Mousse Partners, TPG Biotech

Total Raised

N/A

Valuation

N/A